
Stephen Cornelissen AM
executiveMale0.0Global Dominance: 0.00%
Stephen Cornelissen AM is the CEO of Lifeblood, who recognized the enduring legacy of James Harrison, noting the ongoing research efforts to replicate Harrison's unique antibodies for the development of artificial Anti-D, which aims to prevent hemolytic disease in newborns worldwide.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Stephen Cornelissen AM, the CEO of Lifeblood, stated that James's legacy continues even after his passing.
Người đàn ông cứu sống 2,4 triệu trẻ sơ sinhVnExpress – leading Vietnamese online newspaper, est. 2001·
Vietnam· 2025-03-04


